ArticleFolia microbiologica2025

Targeting virulence of resistant Escherichia coli by the FDA-approved drugs sitagliptin and nitazoxanide as an alternative antimicrobial approach.

Sara M Eltabey et al.PubMed ↗Publisher ↗

No numbers read from the abstract.